USP13 and neurodegenerative disease: Liu et al. designed and synthesized six derivatives of spautin-1 (Figure 4B), which exhibit higher inhibition efficiency against USP13 (Figure 4C) and capability of crossing the blood-brain barrier (Liu et al., 2021a), compared to spautin-1, enabling the development of inhibitors in neurodegenerative diseases.